CITN-06: a Phase I/expansion trial of alt-803, an IL-15 superagonist, in patients with advanced melanoma. (6th November 2014) - Margolin, Kim; Wong, Hing C; Morishima, Chihiro; Hernandez, Liza; Ernstoff, Marc; Rhode, Peter R; Waldmann, Thomas A